Prenetics Reports Record Q4 and FY2025 Revenue; Guides for 2026 Growth
Prenetics Global Limited (NASDAQ: PRE), a health sciences company, reported record financial results for the fourth quarter and full fiscal...
ADVERTISEMENT
Healthcare
Insulet Corporation Reports 31% Annual Revenue Growth; Authorizes $350 Million Repurchase Increase
The global medical technology leader exceeded 2025 financial targets behind a 44% surge in international sales and the expansion of...
Charles River Laboratories (CRL) Q4 revenue, adjusted earnings top expectations
Charles River Laboratories International, Inc. (NYSE: CRL), a provider of products and services for pharma companies to accelerate drug discovery...
AtriCure reports surprise Q4 profit on strong worldwide revenue growth
Shares of AtriCure, Inc. (Nasdaq: ATRC) rose 6.4% to $34.12 in Wednesday morning trading after the medical device maker reported...
Beta Bionics Shares Edge Higher After Q4 Revenue Jumps 57%, Full-Year Sales Top $100 Million
Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday, up about...
cbdMD reports narrowed Q1 net loss, issues going-concern warning
Shares of cbdMD, Inc. (NYSE YCBD) rose 10.72% to $0.78 in Tuesday afternoon trading following the release of its fiscal...
Genmab Q4 2025 Earnings Report: Innovation Push Drives Profit Surge
Genmab A/S (Nasdaq: GMAB) released its full-year 2025 financial results, demonstrating the company’s improved operational execution. Total revenue reached $3.72...
WAY Shares Close at $24.29 After Waystar Reports Q4 2025 Results
Waystar Holding Corp (Nasdaq: WAY) shares closed at $24.29 at the latest U.S. market close following the company’s fourth-quarter and...
Earnings Summary – Labcorp Reports Fourth Quarter and Full Year 2025 Results and Issues 2026 Guidance
Labcorp Holdings Inc. (NYSE: LH), a global leader in laboratory services, released financial results for the fourth quarter and full...
NeoGenomics Full Year 2025 Revenue Rises to $727 Million
NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full...